References
- Adam J , ErikssonKK, SchnyderB, FontanaS, PichlerWJ, YerlyD. Avidity determines T cell reactivity in abacavir hypersensitivity. Eur. J. Immunol.42(7) , 1706–1716 (2012).
- Chessman D , KostenkoL, LethborgT et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28(6) , 822–832 (2008).
- Illing PT , VivianJP, DudekNL et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486(7404) , 554–558 (2012).
- Ostrov DA , GrantBJ, PompeuYA et al. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc. Natl Acad. Sci. USA 109(25) , 9959–9964 (2012).
- Norcross MA , LuoS, LuL et al. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS 26(11) , F21–F29 (2012).
- Buchli R , VanGundyRS, GibersonCF, HildebrandWH. Development and validation of a competition-based peptide binding assay for HLA A*0201 using fluorescence polarization: a new screening tool for epitope discovery. Biochemistry44 , 12491–12507 (2005).
- Buchli R , VanGundyRS, Hickman-MillerHD, GibersonCF, BardetW, HildebrandWH. Real-time measurements of in vitro peptide binding to HLA-A*0201 by fluorescence polarization. Biochemistry43 , 14852–14863 (2004).